These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 29414663)

  • 21. Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?
    Sun C; Xiao X; Yan L; Sheng L; Wang Q; Jiang P; Lian M; Li Y; Wei Y; Zhang J; Chen Y; Li B; Li Y; Huang B; Li Y; Peng Y; Chen X; Fang J; Qiu D; Hua J; Tang R; Leung P; Gershwin ME; Miao Q; Ma X
    J Autoimmun; 2019 May; 99():33-38. PubMed ID: 30709684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of anti-gp210 or anti-sp100 antibodies in AMA-positive patients may help support a diagnosis of primary biliary cholangitis.
    Jaskowski TD; Nandakumar V; Novis CL; Palmer M; Tebo AE
    Clin Chim Acta; 2023 Feb; 540():117219. PubMed ID: 36610465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased mean platelet volume is related to histologic severity of primary biliary cirrhosis.
    Tahtaci M; Yurekli OT; Bolat AD; Balci S; Akin FE; Buyukasik NS; Ersoy O
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1382-5. PubMed ID: 26308712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of transient elastography in assessing liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome.
    Wu HM; Sheng L; Wang Q; Bao H; Miao Q; Xiao X; Guo CJ; Li H; Ma X; Qiu DK; Hua J
    World J Gastroenterol; 2018 Feb; 24(6):737-743. PubMed ID: 29456412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel noninvasive indices for the assessment of liver fibrosis in primary biliary cholangitis.
    Li Y; Zhang MJ; Wang XH; Li SH
    Biomed Rep; 2024 Jan; 20(1):1. PubMed ID: 38222865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Salivary Microbiota of Patients With Primary Biliary Cholangitis Is Distinctive and Pathogenic.
    Lv L; Jiang H; Chen X; Wang Q; Wang K; Ye J; Li Y; Fang D; Lu Y; Yang L; Gu S; Chen J; Diao H; Yan R; Li L
    Front Immunol; 2021; 12():713647. PubMed ID: 34367180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of the primary biliary cholangitis-related serologic profile in a large cohort of Belgian systemic sclerosis patients.
    Florin L; Rubben K; Vanhaecke A; Devreese K; De Keyser F; Smith V; Bonroy C
    Clin Chem Lab Med; 2020 Feb; 58(3):416-423. PubMed ID: 31714880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The contribution of antinuclear antibodies in Primary Biliary Cholangitis (PBC): An experience from the immunology laboratory at University Hospital Center Hassan II, Fes, Morocco.
    Mitri IE; Kaaouch H; Ouboks M; Ballil O
    Qatar Med J; 2023; 2023(2):27. PubMed ID: 38025334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of serum IL-2 levels on the prognosis of primary biliary cholangitis-related liver failure and the preliminary exploration of its mechanism.
    Wang Q; Wang Y; Qiao W; Xu B; Liu Y; Zhang X; Li W; Zhao J; Liu M; Zhang Y; Chen D; Huang C; Jin R
    Front Immunol; 2022; 13():995223. PubMed ID: 36159788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC.
    Chen Z; Liu S; He C; Sun J; Wang L; Chen H; Zhang F
    Front Immunol; 2021; 12():578548. PubMed ID: 33815355
    [No Abstract]   [Full Text] [Related]  

  • 31. The risk predictive values of UK-PBC and GLOBE scoring system in Chinese patients with primary biliary cholangitis: the additional effect of anti-gp210.
    Yang F; Yang Y; Wang Q; Wang Z; Miao Q; Xiao X; Wei Y; Bian Z; Sheng L; Chen X; Qiu D; Fang J; Tang R; Gershwin ME; Ma X
    Aliment Pharmacol Ther; 2017 Mar; 45(5):733-743. PubMed ID: 28083929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating follicular helper T cells presented distinctively different responses toward bacterial antigens in primary biliary cholangitis.
    Zhou ZQ; Tong DN; Guan J; Li MF; Feng QM; Zhou MJ; Zhang ZY
    Int Immunopharmacol; 2017 Oct; 51():76-81. PubMed ID: 28806642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical analysis of primary biliary cirrhosis: a report of 42 cases].
    Dai Y; Liang YH; Xie PY; Chen BW; Liu XG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):410-4. PubMed ID: 16086064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological analysis of anti-mitochondrial antibody negative primary biliary cholangitis-autoimmune hepatitis overlap syndrome].
    Tan XY; Miao Q; Chen XY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):376-380. PubMed ID: 31177663
    [No Abstract]   [Full Text] [Related]  

  • 35. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
    Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
    JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunological characteristics of primary biliary cirrhosis patients].
    Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characteristics of serum chemokine profile in primary biliary cholangitis.
    Mu N; Lin F; Jiang Z; Liang Y; Yang Z
    Cytokine; 2020 Dec; 136():155291. PubMed ID: 32956949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic utility of albumin-bilirubin grade in Japanese patients with primary biliary cholangitis.
    Yamashita Y; Umemura T; Kimura T; Joshita S; Hirohara J; Nakano T; Komori A; Tanaka A
    JHEP Rep; 2023 Apr; 5(4):100662. PubMed ID: 36873419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy.
    Färkkilä M; Rautiainen H; Kärkkäinen P; Karvonen AL; Nurmi H; Niemelä O
    Liver Int; 2008 Jul; 28(6):787-97. PubMed ID: 18397236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune Markers in Primary Biliary Cholangitis.
    Shah SK; Bowlus CL
    Clin Liver Dis; 2024 Feb; 28(1):93-101. PubMed ID: 37945165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.